Tatva Chintan Pharma Chem Ltd (TATVA) is currently trading at 1,380.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer, focusing on Phase Transfer Catalysts, Structure Directing Agents, Electrolyte Salts, and other intermediates. Their key markets include pharmaceuticals, agrochemicals, and electronics. The company reported a robust 48% year-on-year revenue growth for Q2 FY2026, driven by an improved product mix and better operating leverage. Notably, the EBITDA increased by an impressive 298%, indicating enhanced profitability. Tatva Chintan's Structure Directing Agents segment displayed remarkable growth, with a 119% year-on-year revenue increase, attributed to developments in the automotive sector and Euro 7 emission standards. The Electrolyte Salts segment, crucial for energy storage systems, showed substantial demand growth, reflecting significant traction in the market for hybrid battery applications. This positions the company well in the emerging electric vehicle supply chain. Strategic focus on semiconductor chemicals is evident as the company advances in developing ultra-high purity chemicals, a vital component for the electronics industry, aiming for meaningful commercialization in the near future.

Over the past 52 weeks, Tatva Chintan Pharma Chem Ltd has traded between a low of ₹610.00 and a high of ₹1,603.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Tatva Chintan Pharma Chem Ltd has a market capitalization of approximately 3,175.12. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Tatva Chintan Pharma Chem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 179.07 and operates in the Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Tatva Chintan Pharma Chem Ltd (TATVA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 3,175.12 Cr, Tatva Chintan Pharma Chem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Tatva Chintan Pharma Chem Ltd operates in the Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Tatva Chintan Pharma Chem Ltd is 179.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Tatva Chintan Pharma Chem Ltd pays dividends with a current dividend yield of 0.07%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Tatva Chintan Pharma Chem Ltd include sector-specific challenges in the Chemicals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.